These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 38421495)
1. Correction to: Characteristics of splenic PD-1 Chen D; Mo F; Liu M; Liu L; Xing J; Xiao W; Gong Y; Tang S; Tan Z; Liang G; Xie H; Huang J; Shen J; Pan X Immunol Res; 2024 Jun; 72(3):395. PubMed ID: 38421495 [No Abstract] [Full Text] [Related]
2. Characteristics of splenic PD-1 Chen D; Mo F; Liu M; Liu L; Xing J; Xiao W; Gong Y; Tang S; Tan Z; Liang G; Xie H; Huang J; Shen J; Pan X Immunol Res; 2024 Jun; 72(3):383-394. PubMed ID: 38265549 [TBL] [Abstract][Full Text] [Related]
3. Properties and Roles of γδT Cells in Xie H; Xie S; Wang M; Wei H; Huang H; Xie A; Li J; Fang C; Shi F; Yang Q; Qi Y; Yin Z; Wang X; Huang J Front Cell Infect Microbiol; 2021; 11():788546. PubMed ID: 35127555 [TBL] [Abstract][Full Text] [Related]
4. Effect of poly ICLC treatment on hepatic oxidative stress and antioxidant defense indices in Plasmodium yoelii nigeriensis infected mice. Siddiqi NJ; Alhomida AS; Maheshwari RK; Pandey VC In Vivo; 2001; 15(1):77-80. PubMed ID: 11286134 [TBL] [Abstract][Full Text] [Related]
5. Characterization of γδT cells in lung of Plasmodium yoelii-infected C57BL/6 mice. Wei H; Jin C; Peng A; Xie H; Xie S; Feng Y; Xie A; Li J; Fang C; Yang Q; Qiu H; Qi Y; Yin Z; Wang X; Huang J Malar J; 2021 Feb; 20(1):89. PubMed ID: 33588839 [TBL] [Abstract][Full Text] [Related]
6. Resistance reversal action of ketoconazole against mefloquine resistance of Plasmodium yoelii nigeriensis. Awasthi A; Dutta GP; Bhakuni V; Tripathi R Exp Parasitol; 2004; 107(3-4):115-9. PubMed ID: 15363936 [TBL] [Abstract][Full Text] [Related]
7. Immunological characteristics of CD103 Shi F; Tang S; Chen D; Mo F; Li J; Fang C; Wei H; Xing J; Liu L; Gong Y; Tan Z; Zhang Z; Pan X; Zhao S; Huang J Parasitol Res; 2023 Nov; 122(11):2513-2524. PubMed ID: 37707607 [TBL] [Abstract][Full Text] [Related]
9. Characteristics of γδTCR on myeloid cells from C57BL/6 mice with Plasmodium yoelii nigeriensis infection. Chen D; Mo F; Liu M; Ma Y; Liu L; Xing J; Shi F; Xie A; Xie H; Pan X; Wang X; Huang J Mol Biochem Parasitol; 2023 Feb; 253():111540. PubMed ID: 36509228 [TBL] [Abstract][Full Text] [Related]
10. Antagonist effect of chloroquine and tumor necrosis factor on hepatic oxidative stress and antioxidant defense in normal and Plasmodium yoelii nigeriensis-infected mice. Siddiqi NJ; Alhomida AS; Dutta GP; Pandey VC In Vivo; 2002; 16(1):67-70. PubMed ID: 11980364 [TBL] [Abstract][Full Text] [Related]
11. Status of hepatic oxidative stress and antioxidant defense systems during chloroquine treatment of Plasmodium yoelii nigeriensis infected mice. Siddiqi NJ; Alhomida AS In Vivo; 1999; 13(6):547-50. PubMed ID: 10757052 [TBL] [Abstract][Full Text] [Related]
12. Effect of beta-arteether treatment on erythrocytic methemoglobin reductase system in Plasmodium yoelii nigeriensis infected mice. Srivastava S; Alhomida AS; Siddiqi NJ; Pandey VC; Puri SK Drug Chem Toxicol; 2001 May; 24(2):181-90. PubMed ID: 11360434 [TBL] [Abstract][Full Text] [Related]
13. Studies on erythrocytic methemoglobin reductase systems in Plasmodium yoelii nigeriensis infected mice. Srivastava S; Alhomida AS; Siddiqi NJ In Vivo; 2000; 14(4):547-50. PubMed ID: 10945172 [TBL] [Abstract][Full Text] [Related]
14. Plasmodium yoelii nigeriensis (MDR)-efficacy of oral pyronaridine against multidrug-resistant malaria in Swiss mice. Tripathi R; Umesh A; Mishra M; Puri SK; Dutta GP Exp Parasitol; 2000 Mar; 94(3):190-3. PubMed ID: 10831384 [TBL] [Abstract][Full Text] [Related]
15. Studies on hepatic oxidative stress and antioxidant defence systems during arteether treatment of Plasmodium yoelii nigeriensis infected mice. Siddiqi NJ; Pandey VC Mol Cell Biochem; 1999 Jun; 196(1-2):169-73. PubMed ID: 10448917 [TBL] [Abstract][Full Text] [Related]
16. Trials to infect Anopheles stephensi with Plasmodium yoelii nigeriensis by the membrane feeding technique. Chutmongkonkul M; Maier WA; Seitz HM Angew Parasitol; 1992 Nov; 33(4):217-25. PubMed ID: 1456466 [TBL] [Abstract][Full Text] [Related]
17. Effect of Plasmodium yoelii nigeriensis infection on hepatic and splenic glutathione-S-transferase(s) in Swiss albino and db/+ mice: efficacy of mefloquine and menadione in antimalarial chemotherapy. Ahmad R; Srivastava AK Parasitology; 2007 Jul; 134(Pt 7):931-8. PubMed ID: 17352848 [TBL] [Abstract][Full Text] [Related]
18. Changes in rodent-erythrocyte methemoglobin reductase system produced by two malaria parasites, viz. Plasmodium yoelii nigeriensis and Plasmodium berghei. Srivastava S; Alhomida AS; Siddiqi NJ; Pandey VC Comp Biochem Physiol B Biochem Mol Biol; 2001 Jul; 129(4):725-31. PubMed ID: 11435127 [TBL] [Abstract][Full Text] [Related]
19. Effect of tumor necrosis factor on hepatic oxidative stress and antioxidant defense indices in normal and Plasmodium yeolii nigeriensis infected mice. Siddiqi NJ; Alhomida AS; Sharma B; Pandey VC Drug Chem Toxicol; 2000 Nov; 23(4):671-8. PubMed ID: 11071400 [TBL] [Abstract][Full Text] [Related]
20. Synchronization of Plasmodium yoelii nigeriensis and P. y. killicki infection in the mouse by means of Percoll-glucose gradient stage fractionation: determination of the duration of the schizogonic cycle. Deharo E; Gautret P; Ginsburg H; Chabaud AG; Landau I Parasitol Res; 1994; 80(2):159-64. PubMed ID: 8202457 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]